Pfizer Inc
F:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
F:PFE
Watchlist
Price: 21.46 EUR -0.09%
Market Cap: 122B EUR

EV/EBIT
Enterprise Value to EBIT

10.2
Current
10.4
Median
16.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
10.2
=
Enterprise Value
185.8B USD
/
EBIT
18.3B USD
All Countries
Close
Market Cap EV/EBIT
US
Pfizer Inc
F:PFE
143.3B EUR 10.2
US
Eli Lilly and Co
NYSE:LLY
1T USD 39.8
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 21.1
CH
Roche Holding AG
SIX:ROG
262B CHF 13.8
UK
AstraZeneca PLC
LSE:AZN
212.6B GBP 159.7
CH
Novartis AG
SIX:NOVN
210.7B CHF 15.1
US
Merck & Co Inc
NYSE:MRK
260.5B USD 11.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 11.3
IE
Endo International PLC
LSE:0Y5F
209B USD 830.4
FR
Sanofi SA
PAR:SAN
99.5B EUR 6.6
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
F:PFE
Average EV/EBIT: 1 711.1
10.2
8%
1.3
US
Eli Lilly and Co
NYSE:LLY
39.8
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
159.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.5
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
FR
Sanofi SA
PAR:SAN
6.6
15%
0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
8.6
2-Years Forward
EV/EBIT
8.4
3-Years Forward
EV/EBIT
8.7